STOCK TITAN

Korsana Biosciences (KRSA) Revenue by Year

KRSA NASDAQ

Korsana Biosciences, Inc. generated $2.1M in revenue in fiscal year 2025. This represents an increase of 3.7% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Korsana Biosciences, Inc. has filed alongside them.

FY2025 annual
Revenue $2.1M
YoY +3.7%
5Y CAGR -2.0%

Ticker history: CYCN became KRSA (Korsana Biosciences, Inc.) on . Earlier news and filings retain their original names and dates. View CYCN history.

Source SEC Filings Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KRSA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18Filing
Revenue$2.1M+3.7%$2.0Mn/m$0-100.0%$297K-92.5%$3.9M+71.7%$2.3M-49.1%$4.5MN/A

KRSA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'26FilingQ4'25FilingQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
RevenueN/AN/A$0-100.0%$1.0M-43.2%$875K+351.0%$93Kn/m$81Kn/m$1.8Mn/m$194Kn/m$0n/m$0n/m$0

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Korsana Biosciences, Inc. financials

Frequently Asked Questions

Korsana Biosciences, Inc. generated $2.1M in revenue in fiscal year 2025.

Korsana Biosciences, Inc. (KRSA) revenue rose by 3.7% year over year, from $2.0M to $2.1M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Korsana Biosciences, Inc. (KRSA) reported on that line in every period on record.